ALLISON BERUS: Open Payments
NPI 1295210102 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,326 in 72 payments from 11 companies in 2025. Trend: 2023 $1,142 · 2024 $1,678 · 2025 $1,326
Food & beverage: $1,326
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $234 |
| AstraZeneca Pharmaceuticals LP | 11 | $224 |
| GlaxoSmithKline, LLC. | 13 | $203 |
| Lilly USA, LLC | 9 | $154 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $132 |
| Exact Sciences Corporation | 5 | $110 |
| Amgen Inc. | 6 | $105 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| PFIZER INC. | 2 | $36 |
| ABBVIE INC. | 1 | $23 |
Products named: MOUNJARO, SHINGRIX, Ozempic, FARXIGA, JARDIANCE, Cologuard Collection Kit, AIRSUPRA, LEQVIO.
Industry payments across NY — which companies pay providers there.
